290 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CYB561D2Cytochrome b561 family, member D2Predicted membrane proteins
Expressed in all
CYBBCytochrome b-245, beta polypeptideDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
CYBRD1Cytochrome b reductase 1Predicted membrane proteins
Expressed in all
DAGLADiacylglycerol lipase, alphaDisease related genes
Predicted membrane proteins
Tissue enhanced
DCST1DC-STAMP domain containing 1Predicted membrane proteins
Group enriched
DERL2Derlin 2Predicted membrane proteins
Expressed in all
DKFZP761J1410Lipid phosphate phosphatase-related protein type 2 Enzymes
Predicted membrane proteins
Expressed in all
DNAJC22DnaJ (Hsp40) homolog, subfamily C, member 22Predicted membrane proteins
Tissue enhanced
DPY19L4Dpy-19-like 4 (C. elegans)Predicted membrane proteins
Expressed in all
DRAM1DNA-damage regulated autophagy modulator 1Predicted membrane proteins
Expressed in all
DRAM2DNA-damage regulated autophagy modulator 2Predicted membrane proteins
Expressed in all
EI24Etoposide induced 2.4Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
ELOVL1ELOVL fatty acid elongase 1Enzymes
Predicted membrane proteins
Expressed in all
FITM1Fat storage-inducing transmembrane protein 1Predicted membrane proteins
Group enriched
FLVCR2Feline leukemia virus subgroup C cellular receptor family, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Mixed
FRRS1Ferric-chelate reductase 1Predicted membrane proteins
Mixed
FZD6Frizzled family receptor 6Disease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GDPD2Glycerophosphodiester phosphodiesterase domain containing 2Cytoskeleton related proteins
Enzymes
Predicted membrane proteins
Group enriched
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
GHITMGrowth hormone inducible transmembrane proteinPredicted membrane proteins
Expressed in all
GHSRGrowth hormone secretagogue receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Transporters
Not detected
GPR137G protein-coupled receptor 137Predicted membrane proteins
Expressed in all
GPR137CG protein-coupled receptor 137CPredicted membrane proteins
Tissue enriched
GPR149G protein-coupled receptor 149G-protein coupled receptors
Predicted membrane proteins
Not detected
GPR153G protein-coupled receptor 153G-protein coupled receptors
Predicted membrane proteins
Mixed
GPR157G protein-coupled receptor 157G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
GPR31G protein-coupled receptor 31G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
GPR78G protein-coupled receptor 78G-protein coupled receptors
Predicted membrane proteins
Group enriched
GPR83G protein-coupled receptor 83G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
GRINAGlutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)Predicted membrane proteins
Expressed in all
HGSNATHeparan-alpha-glucosaminide N-acetyltransferaseDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
HM13Histocompatibility (minor) 13Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ICMTIsoprenylcysteine carboxyl methyltransferaseEnzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
INSIG2Insulin induced gene 2Predicted membrane proteins
Expressed in all
ITPR2Inositol 1,4,5-trisphosphate receptor, type 2Plasma proteins
Predicted membrane proteins
Mixed
JKAMPJNK1/MAPK8-associated membrane proteinCancer-related genes
Predicted membrane proteins
Expressed in all
KCNA1Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND1Potassium voltage-gated channel, Shal-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH1Potassium voltage-gated channel, subfamily H (eag-related), member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH5Potassium voltage-gated channel, subfamily H (eag-related), member 5Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced

« prev | Page of 6 | next »